⚠ Data freshness notice: the most recent refresh of NHTSA was incomplete, so a
very recent recall may be missing. Everything shown is accurate as of the last checked time on this page —
for anything time-critical, confirm with the official sources linked below.
FDAClass II · Drug · Recalled June 24, 2026
Cura Hongos recall — Dabur India Limited
Hazard: CGMP Deviations; deficiencies observed during FDA inspection
Class II: may cause temporary or medically reversible health consequences.
View the official FDA enforcement record (openFDA) ↗
- Official recall ID
- D-0634-2026
- Brand
- Dabur India
- Classification
- Class II
- Units affected
- 84 tubes
- Recall status
- Ongoing
- Initiated
- Voluntary: Firm initiated
Description
Cura Hongos, Crema Antifungica, Clotrimazole 1%, 2oz (57g) tubes, Dist by/por: Pharmadel LLC, New Castle, DE 19720, Made in India, UPC 8 52924 00683 1.
Affected products
Companies & origin
- Recalling firm location
- Dadra And Nagar Haveli, India
- Firm address
- 225 - 4 - 1 Saily Village, Survey No, N/A
Identifying details (verbatim from the notice)
- Product codes / lots
- Lot# 0003, within expiry
- Distribution
- US Nationwide.
- Firm notified the public via
- E-Mail
- FDA event ID
- 99137
- Recall initiated
- June 2, 2026
- FDA classified
- June 26, 2026
- FDA report date
- June 24, 2026
Source: U.S. Food & Drug Administration. This page mirrors the official public-domain record verbatim;
the linked government source is authoritative. Source last checked July 23, 2026 at 11:04 PM UTC.
Report a data error on this page